Immune-related Adverse Events of Dendritic Cell Vaccination Correlate With Immunologic and Clinical Outcome in Stage III and IV Melanoma Patients

Por Boudewijns, Steve, Westdorp, Harm, Koornstra, Rutger H.T., Aarntzen, Erik H.J.G., Schreibelt, Gerty, Creemers, Jeroen H.A., Punt, Cornelis J.A., Figdor, Carl G., de Vries, I. Jolanda M., Gerritsen, Winald R., Bol, Kalijn F.
Publicado no J Immunother (2016)

Favorable overall survival in stage III melanoma patients after adjuvant dendritic cell vaccination

Por Bol, Kalijn F, Aarntzen, Erik H J G, Hout, Florentien E M in 't, Schreibelt, Gerty, Creemers, Jeroen H A, Lesterhuis, W Joost, Gerritsen, Winald R, Grunhagen, Dirk J, Verhoef, Cornelis, Punt, Cornelis J A, Bonenkamp, Johannes J, de Wilt, Johannes H W, Figdor, Carl G, de Vries, I Jolanda M
Publicado no Oncoimmunology (2015)

Blood-derived dendritic cell vaccinations induce immune responses that correlate with clinical outcome in patients with chemo-naive castration-resistant prostate cancer

Por Westdorp, Harm, Creemers, Jeroen H. A., van Oort, Inge M., Schreibelt, Gerty, Gorris, Mark A. J., Mehra, Niven, Simons, Michiel, de Goede, Anna L., van Rossum, Michelle M., Croockewit, Alexandra J., Figdor, Carl G., Witjes, J. Alfred, Aarntzen, Erik H. J. G., Mus, Roel D. M., Brüning, Mareke, Petry, Katja, Gotthardt, Martin, Barentsz, Jelle O., de Vries, I. Jolanda M., Gerritsen, Winald R.
Publicado no J Immunother Cancer (2019)